Tykvart Jan, Bařinka Cyril, Svoboda Michal, Navrátil Václav, Souček Radko, Hubálek Martin, Hradilek Martin, Šácha Pavel, Lubkowski Jacek, Konvalinka Jan
From the Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo n. 2, Prague 6, Czech Republic, the Departments of Biochemistry and.
the Institute of Biotechnology, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 4, Czech Republic, and.
J Biol Chem. 2015 May 1;290(18):11321-36. doi: 10.1074/jbc.M114.628149. Epub 2015 Mar 9.
N-acetylated α-linked acidic dipeptidase-like protein (NAALADase L), encoded by the NAALADL1 gene, is a close homolog of glutamate carboxypeptidase II, a metallopeptidase that has been intensively studied as a target for imaging and therapy of solid malignancies and neuropathologies. However, neither the physiological functions nor structural features of NAALADase L are known at present. Here, we report a thorough characterization of the protein product of the human NAALADL1 gene, including heterologous overexpression and purification, structural and biochemical characterization, and analysis of its expression profile. By solving the NAALADase L x-ray structure, we provide the first experimental evidence that it is a zinc-dependent metallopeptidase with a catalytic mechanism similar to that of glutamate carboxypeptidase II yet distinct substrate specificity. A proteome-based assay revealed that the NAALADL1 gene product possesses previously unrecognized aminopeptidase activity but no carboxy- or endopeptidase activity. These findings were corroborated by site-directed mutagenesis and identification of bestatin as a potent inhibitor of the enzyme. Analysis of NAALADL1 gene expression at both the mRNA and protein levels revealed the small intestine as the major site of protein expression and points toward extensive alternative splicing of the NAALADL1 gene transcript. Taken together, our data imply that the NAALADL1 gene product's primary physiological function is associated with the final stages of protein/peptide digestion and absorption in the human digestive system. Based on these results, we suggest a new name for this enzyme: human ileal aminopeptidase (HILAP).
由NAALADL1基因编码的N - 乙酰化α - 连接酸性二肽酶样蛋白(NAALADase L)是谷氨酸羧肽酶II的紧密同源物,谷氨酸羧肽酶II是一种金属肽酶,作为实体恶性肿瘤和神经病理学成像及治疗的靶点已得到深入研究。然而,目前NAALADase L的生理功能和结构特征均不明确。在此,我们报告了对人类NAALADL1基因蛋白质产物的全面表征,包括异源过表达与纯化、结构和生化特性以及其表达谱分析。通过解析NAALADase L的X射线结构,我们提供了首个实验证据,表明它是一种锌依赖性金属肽酶,其催化机制与谷氨酸羧肽酶II相似,但底物特异性不同。基于蛋白质组的分析表明,NAALADL1基因产物具有此前未被认识的氨肽酶活性,但没有羧肽酶或内肽酶活性。定点诱变以及鉴定出贝他汀作为该酶的有效抑制剂证实了这些发现。对NAALADL1基因在mRNA和蛋白质水平的表达分析表明,小肠是该蛋白质表达的主要部位,并提示NAALADL1基因转录本存在广泛的可变剪接。综上所述,我们的数据表明NAALADL1基因产物的主要生理功能与人类消化系统中蛋白质/肽消化和吸收的最后阶段相关。基于这些结果,我们为这种酶提出了一个新名称:人回肠氨肽酶(HILAP)。